<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInsurance_valuation</id>
	<title>Definition:Insurance valuation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInsurance_valuation"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_valuation&amp;action=history"/>
	<updated>2026-04-29T23:13:43Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_valuation&amp;diff=12396&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_valuation&amp;diff=12396&amp;oldid=prev"/>
		<updated>2026-03-12T14:53:08Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🔍 &amp;#039;&amp;#039;&amp;#039;Insurance valuation&amp;#039;&amp;#039;&amp;#039; is the process of quantifying the financial worth of an insurance entity&amp;#039;s assets, liabilities, and overall business — encompassing the measurement of [[Definition:Technical provisions | technical provisions]] (reserves for future claims and policyholder obligations), the appraisal of investment portfolios, and, in transactional contexts, the estimation of an insurer&amp;#039;s enterprise or equity value for purposes of [[Definition:Mergers and acquisitions (M&amp;amp;A) | mergers and acquisitions]], [[Definition:Initial public offering (IPO) | IPOs]], or regulatory capital assessments. Unlike valuation in many other industries, insurance valuation is dominated by the challenge of measuring long-tail, uncertain liabilities — promises that may not crystallize for years or even decades — making [[Definition:Actuarial science | actuarial]] judgment and statistical modeling central to the exercise.&lt;br /&gt;
&lt;br /&gt;
📊 The methodology applied depends heavily on the purpose and regulatory context. For statutory and prudential reporting, insurers value their liabilities according to the rules of their home jurisdiction: [[Definition:Solvency II | Solvency II]] requires market-consistent best estimate liabilities plus a [[Definition:Risk margin | risk margin]]; the United States applies formulaic [[Definition:Statutory accounting | statutory accounting]] principles prescribed by the [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]]; [[Definition:IFRS 17 | IFRS 17]] mandates fulfilment cash flows with a [[Definition:Risk adjustment | risk adjustment]] and a [[Definition:Contractual service margin (CSM) | contractual service margin]]; and China&amp;#039;s [[Definition:C-ROSS | C-ROSS]] framework imposes its own capital-oriented valuation basis. In an M&amp;amp;A context, buyers typically perform an [[Definition:Embedded value | embedded value]] or [[Definition:Appraisal value | appraisal value]] analysis for life insurers, projecting future distributable earnings from in-force business and new business potential, while non-life acquisitions often focus on the adequacy of [[Definition:Loss reserves | loss reserves]] and the sustainability of [[Definition:Combined ratio | combined ratios]]. [[Definition:Due diligence | Due diligence]] teams blend actuarial reserve reviews, investment portfolio stress testing, and assessments of intangible value such as distribution networks and technology platforms.&lt;br /&gt;
&lt;br /&gt;
💡 Getting insurance valuation right has consequences that ripple across markets. Undervalued liabilities can mask insolvency until it is too late — as demonstrated by historical failures where [[Definition:Reserves | reserve deficiencies]] went undetected for years — while overly conservative reserving can trap capital unnecessarily and reduce returns to shareholders. For regulators, the valuation basis underpins the entire [[Definition:Solvency | solvency]] framework: if the liability measurement is flawed, capital requirements built on top of it lose meaning. For investors and acquirers, the opacity of insurance balance sheets makes valuation expertise a competitive advantage, and disagreements over reserve adequacy are frequently the most contentious element in [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] negotiations. As global standards converge — with IFRS 17 adoption spreading and the [[Definition:International Association of Insurance Supervisors (IAIS) | IAIS]] promoting comparability through the [[Definition:Insurance capital standard (ICS) | Insurance Capital Standard]] — the practice of insurance valuation is becoming more harmonized, though material differences across jurisdictions will persist for the foreseeable future.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Technical provisions]]&lt;br /&gt;
* [[Definition:Embedded value]]&lt;br /&gt;
* [[Definition:IFRS 17]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Loss reserves]]&lt;br /&gt;
* [[Definition:Actuarial science]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>